DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Melo MJ, Barradas P, Costa A. et al.
Results of a randomized phase III trial comparing 4 cisplatin (P)-based regimens in the treatment of locally advanced and metastatic non-small cell lung cancer (NSCLC): mitomycin/vinblastine/cisplatin (MVP) is no longer a therapeutic option [ASCO Abstract].
Proc Am Soc Clin Oncol 2002; 21: Abstr 1205-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.